✦ LIBER ✦

Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer

✍ Scribed by Park, Sook Ryun; Hong, Yong Sang; Lim, Hyeong-Seok; Seong, Moon-Woo; Kong, Sun-Young; Kim, Sun Young; Park, Young-Iee; Jung, Kyung Hae

Book ID: 121611384
Publisher: Springer
Year: 2013
Tongue: English
Weight: 747 KB
Volume: 72
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-013-2272-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of irinotecan and S-1 comb

Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancer

✍ Yasuhide Yamada; Hisateru Yasui; Ayumu Goto; Tatsuhiro Arai; Takashi Ura; Tetsuy 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 214 KB

A phase I trial of S-1 with oxaliplatin

A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancer

✍ Hyeong Su Kim; Min Jae Park; Ji Eun Uhm; Yuna Lee; Hui Young Lee; Eun Mi Kang; J 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 111 KB

A dose finding and pharmacokinetic study

A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer

✍ Lorenzo Fornaro; G. Masi; S. Bursi; F. Loupakis; E. Vasile; A. Antonuzzo; S. Chi 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 273 KB

A phase I and pharmacokinetic study of i

A phase I and pharmacokinetic study of irinotecan given as a 7 days continuous infusion in metastatic colorectal cancer patients pretreated with 5-FU or raltitrexed

✍ Masi, G.; Di Paolo, A.; Allegrini, G.; Cupini, S.; Galli, C.; Barbara, C.; Danes 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 368 KB

Phase I study of gefitinib, irinotecan,

Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer

✍ Jeffrey A. Meyerhardt; Jeffrey W. Clark; Jeffrey G. Supko; Joseph P. Eder; Shuji 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 329 KB

EPIC: Phase III Trial of Cetuximab Plus

EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer

✍ Sobrero, A. F.; Maurel, J.; Fehrenbacher, L.; Scheithauer, W.; Abubakr, Y. A.; L 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 257 KB